Exane BNP Paribas Reaffirms Neutral Rating on Mapfre SA (MAP)
Mapfre SA (MCE: MAP)‘s stock had its “neutral” rating reiterated by equities research analysts at Exane BNP Paribas in a research note issued to investors on Wednesday. They currently have a $2.60 (€2) price target on the stock.
Several other analysts have also recently commented on the stock. Analysts at Banesto Bolsa SA Sociedad reiterated an “overweight” rating on shares of Mapfre SA in a research note to investors on Tuesday. They now have a $3.22 price target on the stock. Separately, analysts at Bankia Bolsa reiterated a “buy” rating on shares of Mapfre SA in a research note to investors on Monday. They now have a $2.90 price target on the stock.
Mapfre SA is a Spain-based holding company principally engaged in the insurance sector to businesses, professionals and individuals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.
